Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Leukemia, Myeloid, Acute 69 Breast Neoplasms 51 Carcinoma, Non-Small-Cell Lung 29 Neoplasms 27 Myelodysplastic Syndromes 27 Advanced Solid Tumors 27 Advanced Solid Tumor 26 Prostatic Neoplasms 23 Stomach Neoplasms 19 Recurrence 19 Multiple Myeloma 19 Neoplasm Metastasis 18 Carcinoma, Hepatocellular 17 Lung Neoplasms 16 Ovarian Neoplasms 15 Pancreatic Neoplasms 14 Uterine Cervical Neoplasms 13 Solid Tumor 13 Sarcoma 13 Melanoma 13 Leukemia, Myelomonocytic, Chronic 13 Colorectal Neoplasms 12 Triple Negative Breast Neoplasms 10 Small Cell Lung Carcinoma 10 Lymphoma, Large B-Cell, Diffuse 10 Esophageal Neoplasms 9 Squamous Cell Carcinoma of Head and Neck 8 Myeloproliferative Disorders 8 Lymphoma, Non-Hodgkin 8 Lymphoma, B-Cell 7

Interventions

Adalimumab 13 Methotrexate 11 Etanercept 10 Rituximab 5 Abatacept 5 tocilizumab 4 olokizumab 4 tofacitinib 3 golimumab 3 Infliximab 3 Tumor Necrosis Factor Inhibitors 2 Saline Solution 2 RC-18 2 Nivolumab 2 Leflunomide 2 Certolizumab Pegol 2 Antirheumatic Agents 2 veltuzumab 1 upadacitinib 1 secukinumab 1 sarilumab 1 mavrilimumab 1 entecavir 1 cabozantinib 1 baricitinib 1 andecaliximab 1 Vitamin D 1 Vaccines 1 TACI receptor-IgG Fc fragment fusion protein 1 Syringes 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Interventional × Arthritis, Rheumatoid × Injections × Clear all

NCT05090124 2025-01-14

REALISE

NHS Greater Glasgow and Clyde

Phase NA Completed

Arthritis, Rheumatoid

Data powered by HemOnc (CC BY 4.0) Colophon ⚡